비교리스트

 카트 문의
시장보고서
상품코드
1514115

세계의 바이오프리저베이션 시장

Biopreservation
발행일: | 리서치사: Global Industry Analysts, Inc. | 페이지 정보: 영문 178 Pages | 배송안내 : 1-2일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

세계의 바이오프리저베이션 시장은 2030년까지 79억 달러에 달한다

2023년에 46억 달러로 평가된 세계의 바이오프리저베이션 시장은 분석 기간 2023년부터 2030년까지 CAGR 7.9%로 성장할 전망이며, 2030년에는 79억 달러에 이를 것으로 예측됩니다. 본 보고서에서 분석한 부문 중 하나인 바이오프리저베이션 Media는 CAGR 8.7%로 성장을 지속하고, 분석 기간 종료시에는 51억 달러에 달할 것으로 예측됩니다. 바이오프리저베이션 기기 부문의 성장률은 분석 기간 동안 CAGR 6.6%로 추정됩니다.

미국 시장은 12억 달러, 중국은 CAGR 11.9%로 성장 예측

미국의 바이오프리저베이션 시장은 2023년 12억 달러로 평가되었습니다. 세계 2위 경제대국인 중국은 2030년까지 20억 달러 규모에 이를 것으로 예측되며 분석 기간 2023년부터 2030년까지 CAGR은 11.9%로 전망됩니다. 기타 주목할 만한 지역별 시장으로는 일본과 캐나다가 있으며, 분석 기간 중 CAGR은 각각 3.9%와 7.0%로 예측되고 있습니다. 유럽에서는 독일이 CAGR 4.8%로 성장할 것으로 예측됩니다.

세계의 바이오프리저베이션 시장-주요 동향 및 촉진요인 요약

바이오프리저베이션 기술은 세포, 조직, 장기 등의 생체 재료의 기능 수명을 연장하는데 중요한 역할을 담당하고 있으며, 폭넓은 의료 및 과학 용도에 필수적입니다. 이 분야는 보존 방법의 진보, 헬스케어 연구에 대한 정부 및 민간 자금 증가, 다양한 의료 및 연구 분야에 있어서 수요 증가에 의해 큰 성장을 이루고 있습니다. 특히 면역요법, 백신제조, 효소기술 분야에서 유익하며 바이오프리저베이션은 생물학적 물질의 생존가능성 및 기능성을 유지함으로써 만성질환의 발생률 증가를 대처하는 데 도움이 됩니다. 게다가 이 기술은 마이크로어레이나 예측 모델과 같은 정교한 도구를 통합하여 보존 과정을 간소화하고, 특히 심장병과 부인과 같은 중요한 분야에서 진단과 치료 능력을 향상시킵니다.

바이오프리저베이션의 응용은 줄기세포의 보존이나 적정 제조 기준(GMP)에 준거한 세포 치료의 제조에 있어서, 이러한 기술에 크게 의존하고 있는 분야인 바이오뱅크나 재생 의료에 있어서 특히 주목받고 있습니다. 바이오프리저베이션은 생명주기를 통해 '살아있는 약물'을 유지하고 규제 기준을 충족하고 성공적인 상업화를 위해 보존 배지를 최적화하는 복잡한 요구 사항을 지원합니다. 이것은 세포 치료의 생존성을 채취부터 투여까지 유지해야 하는 재생 의료에서 매우 중요합니다. 또한, 저온 보존 및 저체온 보존과 같은 저온 보존 방법은 대사 속도를 낮추고 보존 중 세포 기능과 무결성을 유지하는 데 필수적인 생화학적 요구 사항을 최소화함으로써 이 점에서 매우 중요한 역할을 하고 있습니다.

바이오프리저베이션 시장의 성장 촉진요인으로는 생물학적 시료의 보존 효율을 향상시키는 기술의 진보, 생명 공학 및 의료 분야의 연구 개발 확대, 고급 치료 솔루션이 필요한 만성 질환 증가 등이 있습니다. 생물 시료의 무결성을 유지하기 위해 견고한 바이오프리저베이션을 필요로 하는 바이오뱅크의 세계 확대, 정부 및 민간으로부터의 엄청난 자금 지원이 이러한 성장을 더욱 강화하고 있습니다. 또한, 엄격한 규제 요건은 생물학적 치료 제품이 임상 사용에 안전하고 효과적이라는 것을 보장하기 위해 신뢰할 수 있는 바이오프리저베이션 솔루션이 필요합니다. 개선된 동결보존 기술과 세포 생존율과 회수율을 높이는 새로운 배지 처방 등의 혁신도 중요합니다. 이 분야가 발전함에 따라, 이러한 기술적 진보와 의료 투자 증가의 통합은 의료 및 연구 진보에서 바이오프리저베이션의 중요한 역할을 강조하고, 중요한 생물 자원의 보존과 이용에서 지속적인 확대와 혁신을 약속합니다.

조사 대상 기업 예(총 27건)

  • Atlanta Biologicals, Inc.
  • BioCision, LLC
  • BioGenix, LLC
  • BioLife Solutions, Inc.
  • Biomatrica, Inc.
  • LabVantage Solutions, Inc.
  • Panasonic Corporation
  • Qiagen, Inc.
  • Thermo Fisher Scientific, Inc.
  • VWR International LLC

목차

제1장 조사 방법

제2장 주요 요약

  • 시장 개요
  • 주요 기업
  • 시장 동향 및 촉진요인
  • 세계 시장 전망

제3장 시장 분석

  • 미국
  • 캐나다
  • 일본
  • 중국
  • 유럽
  • 프랑스
  • 독일
  • 이탈리아
  • 영국
  • 스페인
  • 러시아
  • 기타 유럽
  • 아시아태평양
  • 호주
  • 인도
  • 한국
  • 기타 아시아태평양
  • 라틴아메리카
  • 아르헨티나
  • 브라질
  • 멕시코
  • 기타 라틴아메리카
  • 중동
  • 이란
  • 이스라엘
  • 사우디아라비아
  • 아랍에미리트(UAE)
  • 기타 중동
  • 아프리카

제4장 경쟁

AJY 24.07.24

Global Biopreservation Market to Reach US$7.9 Billion by 2030

The global market for Biopreservation estimated at US$4.6 Billion in the year 2023, is expected to reach US$7.9 Billion by 2030, growing at a CAGR of 7.9% over the analysis period 2023-2030. Biopreservation Media, one of the segments analyzed in the report, is expected to record a 8.7% CAGR and reach US$5.1 Billion by the end of the analysis period. Growth in the Biopreservation Equipment segment is estimated at 6.6% CAGR over the analysis period.

The U.S. Market is Estimated at US$1.2 Billion While China is Forecast to Grow at 11.9% CAGR

The Biopreservation market in the U.S. is estimated at US$1.2 Billion in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$2.0 Billion by the year 2030 trailing a CAGR of 11.9% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 3.9% and 7.0% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.8% CAGR.

Global Biopreservation Market - Key Trends and Drivers Summarized

Biopreservation technologies play a crucial role in extending the functional lifespan of biological materials such as cells, tissues, and organs, essential for a broad range of medical and scientific applications. This field has experienced significant growth due to advancements in preservation methods, increased government and private funding for healthcare research, and a rising demand across various medical and research sectors. Particularly beneficial in the realms of immunotherapies, vaccine production, and enzyme technology, biopreservation helps address the growing incidence of chronic diseases by maintaining the viability and functionality of biological materials. Furthermore, the technology incorporates sophisticated tools like microarrays and predictive models which streamline the preservation processes, enhancing diagnosis and treatment capabilities, especially in critical areas such as cardiology and gynecology.

The application of biopreservation is particularly noteworthy in biobanking and regenerative medicine, sectors that heavily rely on these technologies for stem cell preservation and the manufacturing of cell therapies compliant with Good Manufacturing Practices (GMP). Biopreservation supports the intricate requirements of maintaining 'living drugs' through their lifecycle, optimizing preservation media to meet regulatory standards and ensure successful commercialization. This is crucial in regenerative medicine where the viability of cell therapies must be maintained from collection through to administration. Moreover, low-temperature storage methods, like cryogenic and hypothermic storage, play a pivotal role in this regard by reducing metabolic rates and minimizing biochemical requirements, which is vital for preserving cellular function and integrity during storage.

Several growth drivers are propelling the biopreservation market, including technological advancements that improve the efficiency of biological material storage, the expansion of R&D in biotechnology and medicine, and the increasing prevalence of chronic diseases that necessitate advanced therapeutic solutions. The expansion of biobanks globally, which requires robust biopreservation to maintain the integrity of biological samples, along with significant governmental and private funding, further fuels this growth. Additionally, stringent regulatory requirements necessitate reliable biopreservation solutions to ensure that biologically derived therapeutic products are safe and effective for clinical use. Innovations like improved cryopreservation technologies and novel media formulations that enhance cell viability and recovery rates are also crucial. As the field evolves, the integration of these technological advancements with increased healthcare investments underscores the crucial role of biopreservation in advancing healthcare and research, promising continued expansion and innovation in the preservation and utilization of vital biological resources.

Select Competitors (Total 27 Featured) -

  • Atlanta Biologicals, Inc.
  • BioCision, LLC
  • BioGenix, LLC
  • BioLife Solutions, Inc.
  • Biomatrica, Inc.
  • LabVantage Solutions, Inc.
  • Panasonic Corporation
  • Qiagen, Inc.
  • Thermo Fisher Scientific, Inc.
  • VWR International LLC

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Biopreservation - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
    • Global Economic Update
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Growing Demand for Biobanking Services Spurs Growth of Biopreservation Market
    • Advancements in Cryopreservation Techniques Propel Market Expansion
    • Increasing Focus on Regenerative Medicine Expands Addressable Market Opportunity
    • Rising Investments in Stem Cell Research Strengthens Business Case
    • Adoption of Biopreservation in Personalized Medicine Drives Market Adoption
    • Emergence of Advanced Biopreservation Media Throws the Spotlight on Innovation
    • Surge in Clinical Trials and Research Activities Accelerates Demand for Biopreservation
    • Technological Innovations in Automated Storage Systems Sustain Market Growth
    • Decentralization of Biopreservation Facilities Expands Addressable Market
    • Healthcare Spending Propels Market Dynamics
    • Need for Biopreservation in Vaccine Storage and Distribution
    • Need for Long-Term Storage Stability Create Demand for Advanced Solutions
    • Increasing Need for Preservation of Rare and Orphan Disease Samples Drives Adoption
    • Sustainability Concerns Generate Demand for Eco-Friendly Biopreservation Methods
    • Enhanced Efficacy and Safety of Preservation Techniques Propel Market Growth
    • Rising Popularity of Gene Therapy Expands Addressable Market for Biopreservation
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Biopreservation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 2: World 7-Year Perspective for Biopreservation by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2024 & 2030
    • TABLE 3: World Recent Past, Current & Future Analysis for Biopreservation Media by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 4: World 7-Year Perspective for Biopreservation Media by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2024 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Biopreservation Equipment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 6: World 7-Year Perspective for Biopreservation Equipment by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2024 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Human Tissue Samples by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 8: World 7-Year Perspective for Human Tissue Samples by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2024 & 2030
    • TABLE 9: World Recent Past, Current & Future Analysis for Organs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 10: World 7-Year Perspective for Organs by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2024 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Stem Cells by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 12: World 7-Year Perspective for Stem Cells by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2024 & 2030
    • TABLE 13: World Recent Past, Current & Future Analysis for Other Biospecimens by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 14: World 7-Year Perspective for Other Biospecimens by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2024 & 2030
    • TABLE 15: World Recent Past, Current & Future Analysis for Therapeutic Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 16: World 7-Year Perspective for Therapeutic Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2024 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Research Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 18: World 7-Year Perspective for Research Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2024 & 2030
    • TABLE 19: World Recent Past, Current & Future Analysis for Clinical Trials by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 20: World 7-Year Perspective for Clinical Trials by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2024 & 2030
    • TABLE 21: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 22: World 7-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2024 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Biobanks by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 24: World 7-Year Perspective for Biobanks by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2024 & 2030
    • TABLE 25: World Recent Past, Current & Future Analysis for Gene Banks by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 26: World 7-Year Perspective for Gene Banks by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2024 & 2030
    • TABLE 27: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 28: World 7-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2024 & 2030
    • TABLE 29: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 30: World 7-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2024 & 2030
    • TABLE 31: World Biopreservation Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Biopreservation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 32: USA Recent Past, Current & Future Analysis for Biopreservation by Product Type - Biopreservation Media and Biopreservation Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 33: USA 7-Year Perspective for Biopreservation by Product Type - Percentage Breakdown of Value Sales for Biopreservation Media and Biopreservation Equipment for the Years 2024 & 2030
    • TABLE 34: USA Recent Past, Current & Future Analysis for Biopreservation by Application - Therapeutic Applications, Research Applications, Clinical Trials and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 35: USA 7-Year Perspective for Biopreservation by Application - Percentage Breakdown of Value Sales for Therapeutic Applications, Research Applications, Clinical Trials and Other Applications for the Years 2024 & 2030
    • TABLE 36: USA Recent Past, Current & Future Analysis for Biopreservation by Biospecimen - Human Tissue Samples, Organs, Stem Cells and Other Biospecimens - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 37: USA 7-Year Perspective for Biopreservation by Biospecimen - Percentage Breakdown of Value Sales for Human Tissue Samples, Organs, Stem Cells and Other Biospecimens for the Years 2024 & 2030
    • TABLE 38: USA Recent Past, Current & Future Analysis for Biopreservation by End-Use - Biobanks, Gene Banks, Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 39: USA 7-Year Perspective for Biopreservation by End-Use - Percentage Breakdown of Value Sales for Biobanks, Gene Banks, Hospitals and Other End-Uses for the Years 2024 & 2030
  • CANADA
    • TABLE 40: Canada Recent Past, Current & Future Analysis for Biopreservation by Product Type - Biopreservation Media and Biopreservation Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 41: Canada 7-Year Perspective for Biopreservation by Product Type - Percentage Breakdown of Value Sales for Biopreservation Media and Biopreservation Equipment for the Years 2024 & 2030
    • TABLE 42: Canada Recent Past, Current & Future Analysis for Biopreservation by Application - Therapeutic Applications, Research Applications, Clinical Trials and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 43: Canada 7-Year Perspective for Biopreservation by Application - Percentage Breakdown of Value Sales for Therapeutic Applications, Research Applications, Clinical Trials and Other Applications for the Years 2024 & 2030
    • TABLE 44: Canada Recent Past, Current & Future Analysis for Biopreservation by Biospecimen - Human Tissue Samples, Organs, Stem Cells and Other Biospecimens - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 45: Canada 7-Year Perspective for Biopreservation by Biospecimen - Percentage Breakdown of Value Sales for Human Tissue Samples, Organs, Stem Cells and Other Biospecimens for the Years 2024 & 2030
    • TABLE 46: Canada Recent Past, Current & Future Analysis for Biopreservation by End-Use - Biobanks, Gene Banks, Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 47: Canada 7-Year Perspective for Biopreservation by End-Use - Percentage Breakdown of Value Sales for Biobanks, Gene Banks, Hospitals and Other End-Uses for the Years 2024 & 2030
  • JAPAN
    • Biopreservation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 48: Japan Recent Past, Current & Future Analysis for Biopreservation by Product Type - Biopreservation Media and Biopreservation Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 49: Japan 7-Year Perspective for Biopreservation by Product Type - Percentage Breakdown of Value Sales for Biopreservation Media and Biopreservation Equipment for the Years 2024 & 2030
    • TABLE 50: Japan Recent Past, Current & Future Analysis for Biopreservation by Application - Therapeutic Applications, Research Applications, Clinical Trials and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 51: Japan 7-Year Perspective for Biopreservation by Application - Percentage Breakdown of Value Sales for Therapeutic Applications, Research Applications, Clinical Trials and Other Applications for the Years 2024 & 2030
    • TABLE 52: Japan Recent Past, Current & Future Analysis for Biopreservation by Biospecimen - Human Tissue Samples, Organs, Stem Cells and Other Biospecimens - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 53: Japan 7-Year Perspective for Biopreservation by Biospecimen - Percentage Breakdown of Value Sales for Human Tissue Samples, Organs, Stem Cells and Other Biospecimens for the Years 2024 & 2030
    • TABLE 54: Japan Recent Past, Current & Future Analysis for Biopreservation by End-Use - Biobanks, Gene Banks, Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 55: Japan 7-Year Perspective for Biopreservation by End-Use - Percentage Breakdown of Value Sales for Biobanks, Gene Banks, Hospitals and Other End-Uses for the Years 2024 & 2030
  • CHINA
    • Biopreservation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 56: China Recent Past, Current & Future Analysis for Biopreservation by Product Type - Biopreservation Media and Biopreservation Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 57: China 7-Year Perspective for Biopreservation by Product Type - Percentage Breakdown of Value Sales for Biopreservation Media and Biopreservation Equipment for the Years 2024 & 2030
    • TABLE 58: China Recent Past, Current & Future Analysis for Biopreservation by Application - Therapeutic Applications, Research Applications, Clinical Trials and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 59: China 7-Year Perspective for Biopreservation by Application - Percentage Breakdown of Value Sales for Therapeutic Applications, Research Applications, Clinical Trials and Other Applications for the Years 2024 & 2030
    • TABLE 60: China Recent Past, Current & Future Analysis for Biopreservation by Biospecimen - Human Tissue Samples, Organs, Stem Cells and Other Biospecimens - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 61: China 7-Year Perspective for Biopreservation by Biospecimen - Percentage Breakdown of Value Sales for Human Tissue Samples, Organs, Stem Cells and Other Biospecimens for the Years 2024 & 2030
    • TABLE 62: China Recent Past, Current & Future Analysis for Biopreservation by End-Use - Biobanks, Gene Banks, Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 63: China 7-Year Perspective for Biopreservation by End-Use - Percentage Breakdown of Value Sales for Biobanks, Gene Banks, Hospitals and Other End-Uses for the Years 2024 & 2030
  • EUROPE
    • Biopreservation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 64: Europe Recent Past, Current & Future Analysis for Biopreservation by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 65: Europe 7-Year Perspective for Biopreservation by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2024 & 2030
    • TABLE 66: Europe Recent Past, Current & Future Analysis for Biopreservation by Product Type - Biopreservation Media and Biopreservation Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 67: Europe 7-Year Perspective for Biopreservation by Product Type - Percentage Breakdown of Value Sales for Biopreservation Media and Biopreservation Equipment for the Years 2024 & 2030
    • TABLE 68: Europe Recent Past, Current & Future Analysis for Biopreservation by Application - Therapeutic Applications, Research Applications, Clinical Trials and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 69: Europe 7-Year Perspective for Biopreservation by Application - Percentage Breakdown of Value Sales for Therapeutic Applications, Research Applications, Clinical Trials and Other Applications for the Years 2024 & 2030
    • TABLE 70: Europe Recent Past, Current & Future Analysis for Biopreservation by Biospecimen - Human Tissue Samples, Organs, Stem Cells and Other Biospecimens - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 71: Europe 7-Year Perspective for Biopreservation by Biospecimen - Percentage Breakdown of Value Sales for Human Tissue Samples, Organs, Stem Cells and Other Biospecimens for the Years 2024 & 2030
    • TABLE 72: Europe Recent Past, Current & Future Analysis for Biopreservation by End-Use - Biobanks, Gene Banks, Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 73: Europe 7-Year Perspective for Biopreservation by End-Use - Percentage Breakdown of Value Sales for Biobanks, Gene Banks, Hospitals and Other End-Uses for the Years 2024 & 2030
  • FRANCE
    • Biopreservation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 74: France Recent Past, Current & Future Analysis for Biopreservation by Product Type - Biopreservation Media and Biopreservation Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 75: France 7-Year Perspective for Biopreservation by Product Type - Percentage Breakdown of Value Sales for Biopreservation Media and Biopreservation Equipment for the Years 2024 & 2030
    • TABLE 76: France Recent Past, Current & Future Analysis for Biopreservation by Application - Therapeutic Applications, Research Applications, Clinical Trials and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 77: France 7-Year Perspective for Biopreservation by Application - Percentage Breakdown of Value Sales for Therapeutic Applications, Research Applications, Clinical Trials and Other Applications for the Years 2024 & 2030
    • TABLE 78: France Recent Past, Current & Future Analysis for Biopreservation by Biospecimen - Human Tissue Samples, Organs, Stem Cells and Other Biospecimens - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 79: France 7-Year Perspective for Biopreservation by Biospecimen - Percentage Breakdown of Value Sales for Human Tissue Samples, Organs, Stem Cells and Other Biospecimens for the Years 2024 & 2030
    • TABLE 80: France Recent Past, Current & Future Analysis for Biopreservation by End-Use - Biobanks, Gene Banks, Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 81: France 7-Year Perspective for Biopreservation by End-Use - Percentage Breakdown of Value Sales for Biobanks, Gene Banks, Hospitals and Other End-Uses for the Years 2024 & 2030
  • GERMANY
    • Biopreservation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 82: Germany Recent Past, Current & Future Analysis for Biopreservation by Product Type - Biopreservation Media and Biopreservation Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 83: Germany 7-Year Perspective for Biopreservation by Product Type - Percentage Breakdown of Value Sales for Biopreservation Media and Biopreservation Equipment for the Years 2024 & 2030
    • TABLE 84: Germany Recent Past, Current & Future Analysis for Biopreservation by Application - Therapeutic Applications, Research Applications, Clinical Trials and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 85: Germany 7-Year Perspective for Biopreservation by Application - Percentage Breakdown of Value Sales for Therapeutic Applications, Research Applications, Clinical Trials and Other Applications for the Years 2024 & 2030
    • TABLE 86: Germany Recent Past, Current & Future Analysis for Biopreservation by Biospecimen - Human Tissue Samples, Organs, Stem Cells and Other Biospecimens - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 87: Germany 7-Year Perspective for Biopreservation by Biospecimen - Percentage Breakdown of Value Sales for Human Tissue Samples, Organs, Stem Cells and Other Biospecimens for the Years 2024 & 2030
    • TABLE 88: Germany Recent Past, Current & Future Analysis for Biopreservation by End-Use - Biobanks, Gene Banks, Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 89: Germany 7-Year Perspective for Biopreservation by End-Use - Percentage Breakdown of Value Sales for Biobanks, Gene Banks, Hospitals and Other End-Uses for the Years 2024 & 2030
  • ITALY
    • TABLE 90: Italy Recent Past, Current & Future Analysis for Biopreservation by Product Type - Biopreservation Media and Biopreservation Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 91: Italy 7-Year Perspective for Biopreservation by Product Type - Percentage Breakdown of Value Sales for Biopreservation Media and Biopreservation Equipment for the Years 2024 & 2030
    • TABLE 92: Italy Recent Past, Current & Future Analysis for Biopreservation by Application - Therapeutic Applications, Research Applications, Clinical Trials and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 93: Italy 7-Year Perspective for Biopreservation by Application - Percentage Breakdown of Value Sales for Therapeutic Applications, Research Applications, Clinical Trials and Other Applications for the Years 2024 & 2030
    • TABLE 94: Italy Recent Past, Current & Future Analysis for Biopreservation by Biospecimen - Human Tissue Samples, Organs, Stem Cells and Other Biospecimens - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 95: Italy 7-Year Perspective for Biopreservation by Biospecimen - Percentage Breakdown of Value Sales for Human Tissue Samples, Organs, Stem Cells and Other Biospecimens for the Years 2024 & 2030
    • TABLE 96: Italy Recent Past, Current & Future Analysis for Biopreservation by End-Use - Biobanks, Gene Banks, Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 97: Italy 7-Year Perspective for Biopreservation by End-Use - Percentage Breakdown of Value Sales for Biobanks, Gene Banks, Hospitals and Other End-Uses for the Years 2024 & 2030
  • UNITED KINGDOM
    • Biopreservation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 98: UK Recent Past, Current & Future Analysis for Biopreservation by Product Type - Biopreservation Media and Biopreservation Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 99: UK 7-Year Perspective for Biopreservation by Product Type - Percentage Breakdown of Value Sales for Biopreservation Media and Biopreservation Equipment for the Years 2024 & 2030
    • TABLE 100: UK Recent Past, Current & Future Analysis for Biopreservation by Application - Therapeutic Applications, Research Applications, Clinical Trials and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 101: UK 7-Year Perspective for Biopreservation by Application - Percentage Breakdown of Value Sales for Therapeutic Applications, Research Applications, Clinical Trials and Other Applications for the Years 2024 & 2030
    • TABLE 102: UK Recent Past, Current & Future Analysis for Biopreservation by Biospecimen - Human Tissue Samples, Organs, Stem Cells and Other Biospecimens - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 103: UK 7-Year Perspective for Biopreservation by Biospecimen - Percentage Breakdown of Value Sales for Human Tissue Samples, Organs, Stem Cells and Other Biospecimens for the Years 2024 & 2030
    • TABLE 104: UK Recent Past, Current & Future Analysis for Biopreservation by End-Use - Biobanks, Gene Banks, Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 105: UK 7-Year Perspective for Biopreservation by End-Use - Percentage Breakdown of Value Sales for Biobanks, Gene Banks, Hospitals and Other End-Uses for the Years 2024 & 2030
  • SPAIN
    • TABLE 106: Spain Recent Past, Current & Future Analysis for Biopreservation by Product Type - Biopreservation Media and Biopreservation Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 107: Spain 7-Year Perspective for Biopreservation by Product Type - Percentage Breakdown of Value Sales for Biopreservation Media and Biopreservation Equipment for the Years 2024 & 2030
    • TABLE 108: Spain Recent Past, Current & Future Analysis for Biopreservation by Application - Therapeutic Applications, Research Applications, Clinical Trials and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 109: Spain 7-Year Perspective for Biopreservation by Application - Percentage Breakdown of Value Sales for Therapeutic Applications, Research Applications, Clinical Trials and Other Applications for the Years 2024 & 2030
    • TABLE 110: Spain Recent Past, Current & Future Analysis for Biopreservation by Biospecimen - Human Tissue Samples, Organs, Stem Cells and Other Biospecimens - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 111: Spain 7-Year Perspective for Biopreservation by Biospecimen - Percentage Breakdown of Value Sales for Human Tissue Samples, Organs, Stem Cells and Other Biospecimens for the Years 2024 & 2030
    • TABLE 112: Spain Recent Past, Current & Future Analysis for Biopreservation by End-Use - Biobanks, Gene Banks, Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 113: Spain 7-Year Perspective for Biopreservation by End-Use - Percentage Breakdown of Value Sales for Biobanks, Gene Banks, Hospitals and Other End-Uses for the Years 2024 & 2030
  • RUSSIA
    • TABLE 114: Russia Recent Past, Current & Future Analysis for Biopreservation by Product Type - Biopreservation Media and Biopreservation Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 115: Russia 7-Year Perspective for Biopreservation by Product Type - Percentage Breakdown of Value Sales for Biopreservation Media and Biopreservation Equipment for the Years 2024 & 2030
    • TABLE 116: Russia Recent Past, Current & Future Analysis for Biopreservation by Application - Therapeutic Applications, Research Applications, Clinical Trials and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 117: Russia 7-Year Perspective for Biopreservation by Application - Percentage Breakdown of Value Sales for Therapeutic Applications, Research Applications, Clinical Trials and Other Applications for the Years 2024 & 2030
    • TABLE 118: Russia Recent Past, Current & Future Analysis for Biopreservation by Biospecimen - Human Tissue Samples, Organs, Stem Cells and Other Biospecimens - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 119: Russia 7-Year Perspective for Biopreservation by Biospecimen - Percentage Breakdown of Value Sales for Human Tissue Samples, Organs, Stem Cells and Other Biospecimens for the Years 2024 & 2030
    • TABLE 120: Russia Recent Past, Current & Future Analysis for Biopreservation by End-Use - Biobanks, Gene Banks, Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 121: Russia 7-Year Perspective for Biopreservation by End-Use - Percentage Breakdown of Value Sales for Biobanks, Gene Banks, Hospitals and Other End-Uses for the Years 2024 & 2030
  • REST OF EUROPE
    • TABLE 122: Rest of Europe Recent Past, Current & Future Analysis for Biopreservation by Product Type - Biopreservation Media and Biopreservation Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 123: Rest of Europe 7-Year Perspective for Biopreservation by Product Type - Percentage Breakdown of Value Sales for Biopreservation Media and Biopreservation Equipment for the Years 2024 & 2030
    • TABLE 124: Rest of Europe Recent Past, Current & Future Analysis for Biopreservation by Application - Therapeutic Applications, Research Applications, Clinical Trials and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 125: Rest of Europe 7-Year Perspective for Biopreservation by Application - Percentage Breakdown of Value Sales for Therapeutic Applications, Research Applications, Clinical Trials and Other Applications for the Years 2024 & 2030
    • TABLE 126: Rest of Europe Recent Past, Current & Future Analysis for Biopreservation by Biospecimen - Human Tissue Samples, Organs, Stem Cells and Other Biospecimens - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 127: Rest of Europe 7-Year Perspective for Biopreservation by Biospecimen - Percentage Breakdown of Value Sales for Human Tissue Samples, Organs, Stem Cells and Other Biospecimens for the Years 2024 & 2030
    • TABLE 128: Rest of Europe Recent Past, Current & Future Analysis for Biopreservation by End-Use - Biobanks, Gene Banks, Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 129: Rest of Europe 7-Year Perspective for Biopreservation by End-Use - Percentage Breakdown of Value Sales for Biobanks, Gene Banks, Hospitals and Other End-Uses for the Years 2024 & 2030
  • ASIA-PACIFIC
    • Biopreservation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 130: Asia-Pacific Recent Past, Current & Future Analysis for Biopreservation by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 131: Asia-Pacific 7-Year Perspective for Biopreservation by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2024 & 2030
    • TABLE 132: Asia-Pacific Recent Past, Current & Future Analysis for Biopreservation by Product Type - Biopreservation Media and Biopreservation Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 133: Asia-Pacific 7-Year Perspective for Biopreservation by Product Type - Percentage Breakdown of Value Sales for Biopreservation Media and Biopreservation Equipment for the Years 2024 & 2030
    • TABLE 134: Asia-Pacific Recent Past, Current & Future Analysis for Biopreservation by Application - Therapeutic Applications, Research Applications, Clinical Trials and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 135: Asia-Pacific 7-Year Perspective for Biopreservation by Application - Percentage Breakdown of Value Sales for Therapeutic Applications, Research Applications, Clinical Trials and Other Applications for the Years 2024 & 2030
    • TABLE 136: Asia-Pacific Recent Past, Current & Future Analysis for Biopreservation by Biospecimen - Human Tissue Samples, Organs, Stem Cells and Other Biospecimens - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 137: Asia-Pacific 7-Year Perspective for Biopreservation by Biospecimen - Percentage Breakdown of Value Sales for Human Tissue Samples, Organs, Stem Cells and Other Biospecimens for the Years 2024 & 2030
    • TABLE 138: Asia-Pacific Recent Past, Current & Future Analysis for Biopreservation by End-Use - Biobanks, Gene Banks, Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 139: Asia-Pacific 7-Year Perspective for Biopreservation by End-Use - Percentage Breakdown of Value Sales for Biobanks, Gene Banks, Hospitals and Other End-Uses for the Years 2024 & 2030
  • AUSTRALIA
    • Biopreservation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2024 (E)
    • TABLE 140: Australia Recent Past, Current & Future Analysis for Biopreservation by Product Type - Biopreservation Media and Biopreservation Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 141: Australia 7-Year Perspective for Biopreservation by Product Type - Percentage Breakdown of Value Sales for Biopreservation Media and Biopreservation Equipment for the Years 2024 & 2030
    • TABLE 142: Australia Recent Past, Current & Future Analysis for Biopreservation by Application - Therapeutic Applications, Research Applications, Clinical Trials and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 143: Australia 7-Year Perspective for Biopreservation by Application - Percentage Breakdown of Value Sales for Therapeutic Applications, Research Applications, Clinical Trials and Other Applications for the Years 2024 & 2030
    • TABLE 144: Australia Recent Past, Current & Future Analysis for Biopreservation by Biospecimen - Human Tissue Samples, Organs, Stem Cells and Other Biospecimens - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 145: Australia 7-Year Perspective for Biopreservation by Biospecimen - Percentage Breakdown of Value Sales for Human Tissue Samples, Organs, Stem Cells and Other Biospecimens for the Years 2024 & 2030
    • TABLE 146: Australia Recent Past, Current & Future Analysis for Biopreservation by End-Use - Biobanks, Gene Banks, Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 147: Australia 7-Year Perspective for Biopreservation by End-Use - Percentage Breakdown of Value Sales for Biobanks, Gene Banks, Hospitals and Other End-Uses for the Years 2024 & 2030
  • INDIA
    • Biopreservation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2024 (E)
    • TABLE 148: India Recent Past, Current & Future Analysis for Biopreservation by Product Type - Biopreservation Media and Biopreservation Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 149: India 7-Year Perspective for Biopreservation by Product Type - Percentage Breakdown of Value Sales for Biopreservation Media and Biopreservation Equipment for the Years 2024 & 2030
    • TABLE 150: India Recent Past, Current & Future Analysis for Biopreservation by Application - Therapeutic Applications, Research Applications, Clinical Trials and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 151: India 7-Year Perspective for Biopreservation by Application - Percentage Breakdown of Value Sales for Therapeutic Applications, Research Applications, Clinical Trials and Other Applications for the Years 2024 & 2030
    • TABLE 152: India Recent Past, Current & Future Analysis for Biopreservation by Biospecimen - Human Tissue Samples, Organs, Stem Cells and Other Biospecimens - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 153: India 7-Year Perspective for Biopreservation by Biospecimen - Percentage Breakdown of Value Sales for Human Tissue Samples, Organs, Stem Cells and Other Biospecimens for the Years 2024 & 2030
    • TABLE 154: India Recent Past, Current & Future Analysis for Biopreservation by End-Use - Biobanks, Gene Banks, Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 155: India 7-Year Perspective for Biopreservation by End-Use - Percentage Breakdown of Value Sales for Biobanks, Gene Banks, Hospitals and Other End-Uses for the Years 2024 & 2030
  • SOUTH KOREA
    • TABLE 156: South Korea Recent Past, Current & Future Analysis for Biopreservation by Product Type - Biopreservation Media and Biopreservation Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 157: South Korea 7-Year Perspective for Biopreservation by Product Type - Percentage Breakdown of Value Sales for Biopreservation Media and Biopreservation Equipment for the Years 2024 & 2030
    • TABLE 158: South Korea Recent Past, Current & Future Analysis for Biopreservation by Application - Therapeutic Applications, Research Applications, Clinical Trials and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 159: South Korea 7-Year Perspective for Biopreservation by Application - Percentage Breakdown of Value Sales for Therapeutic Applications, Research Applications, Clinical Trials and Other Applications for the Years 2024 & 2030
    • TABLE 160: South Korea Recent Past, Current & Future Analysis for Biopreservation by Biospecimen - Human Tissue Samples, Organs, Stem Cells and Other Biospecimens - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 161: South Korea 7-Year Perspective for Biopreservation by Biospecimen - Percentage Breakdown of Value Sales for Human Tissue Samples, Organs, Stem Cells and Other Biospecimens for the Years 2024 & 2030
    • TABLE 162: South Korea Recent Past, Current & Future Analysis for Biopreservation by End-Use - Biobanks, Gene Banks, Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 163: South Korea 7-Year Perspective for Biopreservation by End-Use - Percentage Breakdown of Value Sales for Biobanks, Gene Banks, Hospitals and Other End-Uses for the Years 2024 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 164: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Biopreservation by Product Type - Biopreservation Media and Biopreservation Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 165: Rest of Asia-Pacific 7-Year Perspective for Biopreservation by Product Type - Percentage Breakdown of Value Sales for Biopreservation Media and Biopreservation Equipment for the Years 2024 & 2030
    • TABLE 166: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Biopreservation by Application - Therapeutic Applications, Research Applications, Clinical Trials and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 167: Rest of Asia-Pacific 7-Year Perspective for Biopreservation by Application - Percentage Breakdown of Value Sales for Therapeutic Applications, Research Applications, Clinical Trials and Other Applications for the Years 2024 & 2030
    • TABLE 168: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Biopreservation by Biospecimen - Human Tissue Samples, Organs, Stem Cells and Other Biospecimens - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 169: Rest of Asia-Pacific 7-Year Perspective for Biopreservation by Biospecimen - Percentage Breakdown of Value Sales for Human Tissue Samples, Organs, Stem Cells and Other Biospecimens for the Years 2024 & 2030
    • TABLE 170: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Biopreservation by End-Use - Biobanks, Gene Banks, Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 171: Rest of Asia-Pacific 7-Year Perspective for Biopreservation by End-Use - Percentage Breakdown of Value Sales for Biobanks, Gene Banks, Hospitals and Other End-Uses for the Years 2024 & 2030
  • LATIN AMERICA
    • Biopreservation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2024 (E)
    • TABLE 172: Latin America Recent Past, Current & Future Analysis for Biopreservation by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 173: Latin America 7-Year Perspective for Biopreservation by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2024 & 2030
    • TABLE 174: Latin America Recent Past, Current & Future Analysis for Biopreservation by Product Type - Biopreservation Media and Biopreservation Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 175: Latin America 7-Year Perspective for Biopreservation by Product Type - Percentage Breakdown of Value Sales for Biopreservation Media and Biopreservation Equipment for the Years 2024 & 2030
    • TABLE 176: Latin America Recent Past, Current & Future Analysis for Biopreservation by Application - Therapeutic Applications, Research Applications, Clinical Trials and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 177: Latin America 7-Year Perspective for Biopreservation by Application - Percentage Breakdown of Value Sales for Therapeutic Applications, Research Applications, Clinical Trials and Other Applications for the Years 2024 & 2030
    • TABLE 178: Latin America Recent Past, Current & Future Analysis for Biopreservation by Biospecimen - Human Tissue Samples, Organs, Stem Cells and Other Biospecimens - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 179: Latin America 7-Year Perspective for Biopreservation by Biospecimen - Percentage Breakdown of Value Sales for Human Tissue Samples, Organs, Stem Cells and Other Biospecimens for the Years 2024 & 2030
    • TABLE 180: Latin America Recent Past, Current & Future Analysis for Biopreservation by End-Use - Biobanks, Gene Banks, Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 181: Latin America 7-Year Perspective for Biopreservation by End-Use - Percentage Breakdown of Value Sales for Biobanks, Gene Banks, Hospitals and Other End-Uses for the Years 2024 & 2030
  • ARGENTINA
    • TABLE 182: Argentina Recent Past, Current & Future Analysis for Biopreservation by Product Type - Biopreservation Media and Biopreservation Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 183: Argentina 7-Year Perspective for Biopreservation by Product Type - Percentage Breakdown of Value Sales for Biopreservation Media and Biopreservation Equipment for the Years 2024 & 2030
    • TABLE 184: Argentina Recent Past, Current & Future Analysis for Biopreservation by Application - Therapeutic Applications, Research Applications, Clinical Trials and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 185: Argentina 7-Year Perspective for Biopreservation by Application - Percentage Breakdown of Value Sales for Therapeutic Applications, Research Applications, Clinical Trials and Other Applications for the Years 2024 & 2030
    • TABLE 186: Argentina Recent Past, Current & Future Analysis for Biopreservation by Biospecimen - Human Tissue Samples, Organs, Stem Cells and Other Biospecimens - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 187: Argentina 7-Year Perspective for Biopreservation by Biospecimen - Percentage Breakdown of Value Sales for Human Tissue Samples, Organs, Stem Cells and Other Biospecimens for the Years 2024 & 2030
    • TABLE 188: Argentina Recent Past, Current & Future Analysis for Biopreservation by End-Use - Biobanks, Gene Banks, Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 189: Argentina 7-Year Perspective for Biopreservation by End-Use - Percentage Breakdown of Value Sales for Biobanks, Gene Banks, Hospitals and Other End-Uses for the Years 2024 & 2030
  • BRAZIL
    • TABLE 190: Brazil Recent Past, Current & Future Analysis for Biopreservation by Product Type - Biopreservation Media and Biopreservation Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 191: Brazil 7-Year Perspective for Biopreservation by Product Type - Percentage Breakdown of Value Sales for Biopreservation Media and Biopreservation Equipment for the Years 2024 & 2030
    • TABLE 192: Brazil Recent Past, Current & Future Analysis for Biopreservation by Application - Therapeutic Applications, Research Applications, Clinical Trials and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 193: Brazil 7-Year Perspective for Biopreservation by Application - Percentage Breakdown of Value Sales for Therapeutic Applications, Research Applications, Clinical Trials and Other Applications for the Years 2024 & 2030
    • TABLE 194: Brazil Recent Past, Current & Future Analysis for Biopreservation by Biospecimen - Human Tissue Samples, Organs, Stem Cells and Other Biospecimens - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 195: Brazil 7-Year Perspective for Biopreservation by Biospecimen - Percentage Breakdown of Value Sales for Human Tissue Samples, Organs, Stem Cells and Other Biospecimens for the Years 2024 & 2030
    • TABLE 196: Brazil Recent Past, Current & Future Analysis for Biopreservation by End-Use - Biobanks, Gene Banks, Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 197: Brazil 7-Year Perspective for Biopreservation by End-Use - Percentage Breakdown of Value Sales for Biobanks, Gene Banks, Hospitals and Other End-Uses for the Years 2024 & 2030
  • MEXICO
    • TABLE 198: Mexico Recent Past, Current & Future Analysis for Biopreservation by Product Type - Biopreservation Media and Biopreservation Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 199: Mexico 7-Year Perspective for Biopreservation by Product Type - Percentage Breakdown of Value Sales for Biopreservation Media and Biopreservation Equipment for the Years 2024 & 2030
    • TABLE 200: Mexico Recent Past, Current & Future Analysis for Biopreservation by Application - Therapeutic Applications, Research Applications, Clinical Trials and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 201: Mexico 7-Year Perspective for Biopreservation by Application - Percentage Breakdown of Value Sales for Therapeutic Applications, Research Applications, Clinical Trials and Other Applications for the Years 2024 & 2030
    • TABLE 202: Mexico Recent Past, Current & Future Analysis for Biopreservation by Biospecimen - Human Tissue Samples, Organs, Stem Cells and Other Biospecimens - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 203: Mexico 7-Year Perspective for Biopreservation by Biospecimen - Percentage Breakdown of Value Sales for Human Tissue Samples, Organs, Stem Cells and Other Biospecimens for the Years 2024 & 2030
    • TABLE 204: Mexico Recent Past, Current & Future Analysis for Biopreservation by End-Use - Biobanks, Gene Banks, Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 205: Mexico 7-Year Perspective for Biopreservation by End-Use - Percentage Breakdown of Value Sales for Biobanks, Gene Banks, Hospitals and Other End-Uses for the Years 2024 & 2030
  • REST OF LATIN AMERICA
    • TABLE 206: Rest of Latin America Recent Past, Current & Future Analysis for Biopreservation by Product Type - Biopreservation Media and Biopreservation Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 207: Rest of Latin America 7-Year Perspective for Biopreservation by Product Type - Percentage Breakdown of Value Sales for Biopreservation Media and Biopreservation Equipment for the Years 2024 & 2030
    • TABLE 208: Rest of Latin America Recent Past, Current & Future Analysis for Biopreservation by Application - Therapeutic Applications, Research Applications, Clinical Trials and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 209: Rest of Latin America 7-Year Perspective for Biopreservation by Application - Percentage Breakdown of Value Sales for Therapeutic Applications, Research Applications, Clinical Trials and Other Applications for the Years 2024 & 2030
    • TABLE 210: Rest of Latin America Recent Past, Current & Future Analysis for Biopreservation by Biospecimen - Human Tissue Samples, Organs, Stem Cells and Other Biospecimens - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 211: Rest of Latin America 7-Year Perspective for Biopreservation by Biospecimen - Percentage Breakdown of Value Sales for Human Tissue Samples, Organs, Stem Cells and Other Biospecimens for the Years 2024 & 2030
    • TABLE 212: Rest of Latin America Recent Past, Current & Future Analysis for Biopreservation by End-Use - Biobanks, Gene Banks, Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 213: Rest of Latin America 7-Year Perspective for Biopreservation by End-Use - Percentage Breakdown of Value Sales for Biobanks, Gene Banks, Hospitals and Other End-Uses for the Years 2024 & 2030
  • MIDDLE EAST
    • Biopreservation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2024 (E)
    • TABLE 214: Middle East Recent Past, Current & Future Analysis for Biopreservation by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 215: Middle East 7-Year Perspective for Biopreservation by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2024 & 2030
    • TABLE 216: Middle East Recent Past, Current & Future Analysis for Biopreservation by Product Type - Biopreservation Media and Biopreservation Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 217: Middle East 7-Year Perspective for Biopreservation by Product Type - Percentage Breakdown of Value Sales for Biopreservation Media and Biopreservation Equipment for the Years 2024 & 2030
    • TABLE 218: Middle East Recent Past, Current & Future Analysis for Biopreservation by Application - Therapeutic Applications, Research Applications, Clinical Trials and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 219: Middle East 7-Year Perspective for Biopreservation by Application - Percentage Breakdown of Value Sales for Therapeutic Applications, Research Applications, Clinical Trials and Other Applications for the Years 2024 & 2030
    • TABLE 220: Middle East Recent Past, Current & Future Analysis for Biopreservation by Biospecimen - Human Tissue Samples, Organs, Stem Cells and Other Biospecimens - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 221: Middle East 7-Year Perspective for Biopreservation by Biospecimen - Percentage Breakdown of Value Sales for Human Tissue Samples, Organs, Stem Cells and Other Biospecimens for the Years 2024 & 2030
    • TABLE 222: Middle East Recent Past, Current & Future Analysis for Biopreservation by End-Use - Biobanks, Gene Banks, Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 223: Middle East 7-Year Perspective for Biopreservation by End-Use - Percentage Breakdown of Value Sales for Biobanks, Gene Banks, Hospitals and Other End-Uses for the Years 2024 & 2030
  • IRAN
    • TABLE 224: Iran Recent Past, Current & Future Analysis for Biopreservation by Product Type - Biopreservation Media and Biopreservation Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 225: Iran 7-Year Perspective for Biopreservation by Product Type - Percentage Breakdown of Value Sales for Biopreservation Media and Biopreservation Equipment for the Years 2024 & 2030
    • TABLE 226: Iran Recent Past, Current & Future Analysis for Biopreservation by Application - Therapeutic Applications, Research Applications, Clinical Trials and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 227: Iran 7-Year Perspective for Biopreservation by Application - Percentage Breakdown of Value Sales for Therapeutic Applications, Research Applications, Clinical Trials and Other Applications for the Years 2024 & 2030
    • TABLE 228: Iran Recent Past, Current & Future Analysis for Biopreservation by Biospecimen - Human Tissue Samples, Organs, Stem Cells and Other Biospecimens - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 229: Iran 7-Year Perspective for Biopreservation by Biospecimen - Percentage Breakdown of Value Sales for Human Tissue Samples, Organs, Stem Cells and Other Biospecimens for the Years 2024 & 2030
    • TABLE 230: Iran Recent Past, Current & Future Analysis for Biopreservation by End-Use - Biobanks, Gene Banks, Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 231: Iran 7-Year Perspective for Biopreservation by End-Use - Percentage Breakdown of Value Sales for Biobanks, Gene Banks, Hospitals and Other End-Uses for the Years 2024 & 2030
  • ISRAEL
    • TABLE 232: Israel Recent Past, Current & Future Analysis for Biopreservation by Product Type - Biopreservation Media and Biopreservation Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 233: Israel 7-Year Perspective for Biopreservation by Product Type - Percentage Breakdown of Value Sales for Biopreservation Media and Biopreservation Equipment for the Years 2024 & 2030
    • TABLE 234: Israel Recent Past, Current & Future Analysis for Biopreservation by Application - Therapeutic Applications, Research Applications, Clinical Trials and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 235: Israel 7-Year Perspective for Biopreservation by Application - Percentage Breakdown of Value Sales for Therapeutic Applications, Research Applications, Clinical Trials and Other Applications for the Years 2024 & 2030
    • TABLE 236: Israel Recent Past, Current & Future Analysis for Biopreservation by Biospecimen - Human Tissue Samples, Organs, Stem Cells and Other Biospecimens - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 237: Israel 7-Year Perspective for Biopreservation by Biospecimen - Percentage Breakdown of Value Sales for Human Tissue Samples, Organs, Stem Cells and Other Biospecimens for the Years 2024 & 2030
    • TABLE 238: Israel Recent Past, Current & Future Analysis for Biopreservation by End-Use - Biobanks, Gene Banks, Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 239: Israel 7-Year Perspective for Biopreservation by End-Use - Percentage Breakdown of Value Sales for Biobanks, Gene Banks, Hospitals and Other End-Uses for the Years 2024 & 2030
  • SAUDI ARABIA
    • TABLE 240: Saudi Arabia Recent Past, Current & Future Analysis for Biopreservation by Product Type - Biopreservation Media and Biopreservation Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 241: Saudi Arabia 7-Year Perspective for Biopreservation by Product Type - Percentage Breakdown of Value Sales for Biopreservation Media and Biopreservation Equipment for the Years 2024 & 2030
    • TABLE 242: Saudi Arabia Recent Past, Current & Future Analysis for Biopreservation by Application - Therapeutic Applications, Research Applications, Clinical Trials and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 243: Saudi Arabia 7-Year Perspective for Biopreservation by Application - Percentage Breakdown of Value Sales for Therapeutic Applications, Research Applications, Clinical Trials and Other Applications for the Years 2024 & 2030
    • TABLE 244: Saudi Arabia Recent Past, Current & Future Analysis for Biopreservation by Biospecimen - Human Tissue Samples, Organs, Stem Cells and Other Biospecimens - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 245: Saudi Arabia 7-Year Perspective for Biopreservation by Biospecimen - Percentage Breakdown of Value Sales for Human Tissue Samples, Organs, Stem Cells and Other Biospecimens for the Years 2024 & 2030
    • TABLE 246: Saudi Arabia Recent Past, Current & Future Analysis for Biopreservation by End-Use - Biobanks, Gene Banks, Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 247: Saudi Arabia 7-Year Perspective for Biopreservation by End-Use - Percentage Breakdown of Value Sales for Biobanks, Gene Banks, Hospitals and Other End-Uses for the Years 2024 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 248: UAE Recent Past, Current & Future Analysis for Biopreservation by Product Type - Biopreservation Media and Biopreservation Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 249: UAE 7-Year Perspective for Biopreservation by Product Type - Percentage Breakdown of Value Sales for Biopreservation Media and Biopreservation Equipment for the Years 2024 & 2030
    • TABLE 250: UAE Recent Past, Current & Future Analysis for Biopreservation by Application - Therapeutic Applications, Research Applications, Clinical Trials and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 251: UAE 7-Year Perspective for Biopreservation by Application - Percentage Breakdown of Value Sales for Therapeutic Applications, Research Applications, Clinical Trials and Other Applications for the Years 2024 & 2030
    • TABLE 252: UAE Recent Past, Current & Future Analysis for Biopreservation by Biospecimen - Human Tissue Samples, Organs, Stem Cells and Other Biospecimens - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 253: UAE 7-Year Perspective for Biopreservation by Biospecimen - Percentage Breakdown of Value Sales for Human Tissue Samples, Organs, Stem Cells and Other Biospecimens for the Years 2024 & 2030
    • TABLE 254: UAE Recent Past, Current & Future Analysis for Biopreservation by End-Use - Biobanks, Gene Banks, Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 255: UAE 7-Year Perspective for Biopreservation by End-Use - Percentage Breakdown of Value Sales for Biobanks, Gene Banks, Hospitals and Other End-Uses for the Years 2024 & 2030
  • REST OF MIDDLE EAST
    • TABLE 256: Rest of Middle East Recent Past, Current & Future Analysis for Biopreservation by Product Type - Biopreservation Media and Biopreservation Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 257: Rest of Middle East 7-Year Perspective for Biopreservation by Product Type - Percentage Breakdown of Value Sales for Biopreservation Media and Biopreservation Equipment for the Years 2024 & 2030
    • TABLE 258: Rest of Middle East Recent Past, Current & Future Analysis for Biopreservation by Application - Therapeutic Applications, Research Applications, Clinical Trials and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 259: Rest of Middle East 7-Year Perspective for Biopreservation by Application - Percentage Breakdown of Value Sales for Therapeutic Applications, Research Applications, Clinical Trials and Other Applications for the Years 2024 & 2030
    • TABLE 260: Rest of Middle East Recent Past, Current & Future Analysis for Biopreservation by Biospecimen - Human Tissue Samples, Organs, Stem Cells and Other Biospecimens - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 261: Rest of Middle East 7-Year Perspective for Biopreservation by Biospecimen - Percentage Breakdown of Value Sales for Human Tissue Samples, Organs, Stem Cells and Other Biospecimens for the Years 2024 & 2030
    • TABLE 262: Rest of Middle East Recent Past, Current & Future Analysis for Biopreservation by End-Use - Biobanks, Gene Banks, Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 263: Rest of Middle East 7-Year Perspective for Biopreservation by End-Use - Percentage Breakdown of Value Sales for Biobanks, Gene Banks, Hospitals and Other End-Uses for the Years 2024 & 2030
  • AFRICA
    • Biopreservation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2024 (E)
    • TABLE 264: Africa Recent Past, Current & Future Analysis for Biopreservation by Product Type - Biopreservation Media and Biopreservation Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 265: Africa 7-Year Perspective for Biopreservation by Product Type - Percentage Breakdown of Value Sales for Biopreservation Media and Biopreservation Equipment for the Years 2024 & 2030
    • TABLE 266: Africa Recent Past, Current & Future Analysis for Biopreservation by Application - Therapeutic Applications, Research Applications, Clinical Trials and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 267: Africa 7-Year Perspective for Biopreservation by Application - Percentage Breakdown of Value Sales for Therapeutic Applications, Research Applications, Clinical Trials and Other Applications for the Years 2024 & 2030
    • TABLE 268: Africa Recent Past, Current & Future Analysis for Biopreservation by Biospecimen - Human Tissue Samples, Organs, Stem Cells and Other Biospecimens - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 269: Africa 7-Year Perspective for Biopreservation by Biospecimen - Percentage Breakdown of Value Sales for Human Tissue Samples, Organs, Stem Cells and Other Biospecimens for the Years 2024 & 2030
    • TABLE 270: Africa Recent Past, Current & Future Analysis for Biopreservation by End-Use - Biobanks, Gene Banks, Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 271: Africa 7-Year Perspective for Biopreservation by End-Use - Percentage Breakdown of Value Sales for Biobanks, Gene Banks, Hospitals and Other End-Uses for the Years 2024 & 2030

IV. COMPETITION

비교리스트
0 건의 상품을 선택 중
상품 비교하기
전체삭제